Male circumcision in HIV prevention

Lancet

Volumn 369, Issue 9573, 2007, Pages 1597-

  Kalichman, Seth C ^a   Eaton, Lisa ^a   Pinkerton, Steven D ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMCISION; CONDOM; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LETTER; PRIORITY JOURNAL; SEROCONVERSION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION; ATTITUDE TO HEALTH; COITUS; DISEASE TRANSMISSION; MALE; NOTE; PSYCHOLOGICAL ASPECT; UTILIZATION REVIEW;

ATTITUDE TO HEALTH; CIRCUMCISION, MALE; COITUS; CONDOMS; HIV INFECTIONS; HUMANS; MALE; SEXUALLY TRANSMITTED DISEASES;

EID: 34248149847     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60734-X     Document Type: Letter

References (5)

1. Bailey R., Moses S., Parker C., et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369 (2007) 643-656
2. Gray R., Kigozi G., Serwadda D., et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369 (2007) 657-666
3. Williams B., Lloyd-Smith J., Gouws E., et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 3 (2006) e262
4. Fleming D., and Wasserheit J. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75 (1999) 3-17
5. Chesson H., and Pinkerton S. Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J Acquir Immune Defic Syndr 24 (2000) 48-55